๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The role of serum prostatc acid phosphatase in the management of adenocarcinoma of the prostate with radiotherapy

โœ Scribed by Jeffrey C. Carlton; Gunar K. Zagars; Mary J. Oswald

Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
858 KB
Volume
19
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Serum prostatic acid-phosphatase levels
Serum prostatic acid-phosphatase levels in proved cases of carcinoma or benign hypertrophy of the prostate
โœ Willet F. Whitmore Jr.; Oscar Bodansky; Morton K. Schwartz; Sai Hou Ying; Emerso ๐Ÿ“‚ Article ๐Ÿ“… 1956 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 514 KB

N 1953 Fishman and Lerner reported a tech-I nique for the determination of that portion of the serum acid phosphatasc that originates from the prostate.9 T h e method is based on the observation of Abul-Fad1 and King that L-tartrate inhibits prostatic acid phosphatase. Fishman and co-workers77 8 sub

The role of radiotherapy in the manageme
The role of radiotherapy in the management of malignant thymoma
โœ C. R. H. Penn; H. F. Hope-Stone ๐Ÿ“‚ Article ๐Ÿ“… 1972 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 702 KB

Abstract A series of 18 cases of malignant thymoma referred for radiotherapy during a 21-year period is reviewed. The presentation, treatment policy, and results are examined. Of the 7 cases treated with a full radical dose all were alive at 3 years, all 4 cases followed for 5 years survived that pe